[ad_1] US shares closed decrease for a second straight session on Tuesday after information indicating that the labor market remained…
[ad_1] Textual content dimension Some analysts are hoping Pfizer will use its Covid-19 windfall for acquisitions. Mario Tama/Getty Pictures Pfizer…
[ad_1] Pfizer Inc expects to roughly quadruple the worth of its COVID-19 vaccine to about $110 to $130 per dose…
[ad_1] Mumbai: Pharma was usually handed over by traders looking for multi-bagger returns when cash was low cost and shares…
[ad_1] If 2022 have been to finish tomorrow, or the day after, it might enter the books as a dismal…